Takara Bio

4974.T

Key numbers · FY ended 2025-03

Revenue¥45.0bn+3.5% YoY Operating income¥2.3bn-24.6% YoY Net income (owners)¥1.0bn-29.7% YoY Total assets¥125.3bn+3.4% YoY EPS (basic)¥8.65-29.7% YoY

Full financial history and reports →

Stock price4974 · View chart ↗

Open the price chart on TradingView.

Latest filings

Tue, Apr 21 · JST1 filing

10:345% STAKETakara Bio · Nomura Asset Management Co., Ltd. + 1 joint holder · 5.32% → 1.99%−3.33pp

Thu, Apr 9 · JST1 filing

13:015% STAKETakara Bio · TAKARA HOLDINGS INC. · 61.08% → 87.27%+26.19pp

Mon, Feb 16 · JST1 filing

16:42TOBTakara Bio · TAKARA BIO INC. board files opinion on tender offer

Thu, Oct 23 · JST1 filing

15:56MATERIALTakara Bio · Event with a material impact on financial position

Tue, May 13 · JST1 filing

16:11MATERIALTakara Bio · Change of representative director

All filings →

Major holders (5%+) · 1

Holder	Stake	Change	Filed
TAKARA HOLDINGS INC.	87.27%	—	2026-04-09

Each holder's own ratio from its most recent large-shareholding report.